References
- Bode CJ, Jin H, Rytting E, Silverstein PS, Young AM, Audus KL. 2006. In vitro models for studying trophoblast transcellular transport. Methods Mol Med 122:225–39
- Cariappa R, Heath-Monnig E, Smith CH. 2003. Isoforms of amino acid transporters in placental syncytiotrophoblast: plasma membrane localization and potential role in maternal/fetal transport. Placenta 24:713–26
- Choi J-Y, Ramachandran G, Kandlikar M. 2009. The impact of toxicity testing costs on nanomaterial regulation. Environ Sci Technol 43:3030–4
- Correia Carreira S, Cartwright L, Mathiesen L, Knudsen LE, Saunders M. 2011. Studying placental transfer of highly purified non-dioxin-like PCBs in two models of the placental barrier. Placenta 32:283–91
- Correia Carreira S, Walker L, Paul K, Saunders M. 2015. The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier model used within NanoTEST. Nanotoxicology 9(S1):66–78
- Günday N, Schneider M. 2012. Conference scene: nanomedicine and nanotoxicology: future prospects and the need for translational factors for the combination of both. Nanomedicine (London, England) 7:811–14
- Jin H, Audus KL. 2005. Effect of bisphenol A on drug efflux in BeWo, a human trophoblast-like cell line. Placenta 26:S96–103
- Levkovitz R, Zaretsky U, Gordon Z, Jaffa AJ, Elad D. 2013. In vitro simulation of placental transport: Part I. Biological model of the placental barrier. Placenta 34:699–707
- Li H, van Ravenzwaay B, Rietjens IM, Louisse J. 2013. Assessment of an in vitro transport model using BeWo b30 cells to predict placental transfer of compounds. Arch Toxicol 87:1661–9
- Miller RK, Genbacev O, Turner MA, Aplin JD, Caniggia I, Huppertz B. 2005. Human placental explants in culture: approaches and assessments. Placenta 26:439–48
- PEN. 2013. The Project on Emerging Nanotechnologies. Consumer Products Inventory. Available at: http://www.nanotechproject.org/cpi/. Last accessed on Nov 11, 2013
- Poulsen MS, Rytting E, Mose T, Knudsen LE. 2009. Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion. Toxicol In Vitro 23:1380–6
- Prouillac C, Lecoeur S. 2010. The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies. Drug Metab Dispos 38:1623–35
- Sastry BVR. 1996. Techniques: cultured tissues and cells to study placental function. In: Sastry BVR, ed. Placental Pharmacology. London: CRC Press, 47–66
- Saunders M. 2009. Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:671–84
- Sood A, Salih S, Roh D, Lacharme-Lora L, Parry M, Hardiman B, et al. 2011. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nat Nanotechnol 6:824–33
- Thadani PV, Strauss JF III, Dey SK, Anderson VM, Audus KL, Coats KS, et al. 2004. National Institute on Drug Abuse Conference report on placental proteins, drug transport, and fetal development. Am J Obstet Gynecol 191:1858–62
- Vähäkangas K, Myllynen P. 2006. Experimental methods to study human transplacental exposure to genotoxic agents. Mutat Res 608:129–35